Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC)

NCT04326920 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

87

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Sargramostim
OTHER: Control

Sponsor

University Hospital, Ghent

Collaborators

[object Object]